The Car-T cell therapy was tested on patients with B-cell leukaemia and lymphoma - rare types of blood cancers - that affect the bone marrow and the lymphatic system.
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...
An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback